Market Closed -
Singapore S.E.
05:04:34 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.021
SGD
|
0.00%
|
|
+5.00%
|
-19.23%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
174.3
|
159.9
|
805.6
|
711.6
|
829.1
|
278.2
|
Enterprise Value (EV)
1 |
59.33
|
208.9
|
695.8
|
17.64
|
-208.5
|
-140
|
P/E ratio
|
7.9
x
|
-0.64
x
|
4.31
x
|
2.19
x
|
1.69
x
|
-0.81
x
|
Yield
|
-
|
-
|
-
|
6.19%
|
11.1%
|
34.6%
|
Capitalization / Revenue
|
0.13
x
|
0.15
x
|
0.7
x
|
0.33
x
|
0.34
x
|
0.46
x
|
EV / Revenue
|
0.05
x
|
0.2
x
|
0.61
x
|
0.01
x
|
-0.09
x
|
-0.23
x
|
EV / EBITDA
|
0.52
x
|
3.49
x
|
2.62
x
|
0.03
x
|
-0.31
x
|
0.5
x
|
EV / FCF
|
1.17
x
|
4.85
x
|
8.35
x
|
0.03
x
|
-0.61
x
|
0.38
x
|
FCF Yield
|
85.3%
|
20.6%
|
12%
|
3,929%
|
-165%
|
266%
|
Price to Book
|
0.32
x
|
0.53
x
|
1.54
x
|
0.87
x
|
0.68
x
|
0.36
x
|
Nbr of stocks (in thousands)
|
1,818,444
|
1,818,444
|
1,988,444
|
1,988,444
|
1,988,444
|
1,988,444
|
Reference price
2 |
0.0959
|
0.0879
|
0.4051
|
0.3579
|
0.4170
|
0.1399
|
Announcement Date
|
4/9/19
|
4/15/20
|
4/12/21
|
4/6/22
|
4/11/23
|
4/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,308
|
1,054
|
1,146
|
2,173
|
2,435
|
598.6
|
EBITDA
1 |
113.5
|
59.9
|
265.7
|
639.6
|
667.9
|
-282.5
|
EBIT
1 |
84.39
|
32.08
|
239.2
|
610.6
|
645.6
|
-305.7
|
Operating Margin
|
6.45%
|
3.04%
|
20.87%
|
28.09%
|
26.51%
|
-51.07%
|
Earnings before Tax (EBT)
1 |
35.21
|
-269.4
|
242.4
|
485.1
|
672
|
-346.9
|
Net income
1 |
22.08
|
-248.4
|
173.7
|
324.9
|
490.5
|
-344.6
|
Net margin
|
1.69%
|
-23.56%
|
15.15%
|
14.95%
|
20.14%
|
-57.58%
|
EPS
2 |
0.0121
|
-0.1366
|
0.0939
|
0.1634
|
0.2467
|
-0.1733
|
Free Cash Flow
1 |
50.58
|
43.03
|
83.31
|
693.1
|
344.2
|
-371.9
|
FCF margin
|
3.87%
|
4.08%
|
7.27%
|
31.89%
|
14.14%
|
-62.13%
|
FCF Conversion (EBITDA)
|
44.57%
|
71.83%
|
31.36%
|
108.37%
|
51.54%
|
-
|
FCF Conversion (Net income)
|
229.08%
|
-
|
47.97%
|
213.33%
|
70.18%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.0221
|
0.0463
|
0.0483
|
Announcement Date
|
4/9/19
|
4/15/20
|
4/12/21
|
4/6/22
|
4/11/23
|
4/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
49
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
115
|
-
|
110
|
694
|
1,038
|
418
|
Leverage (Debt/EBITDA)
|
-
|
0.8172
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
50.6
|
43
|
83.3
|
693
|
344
|
-372
|
ROE (net income / shareholders' equity)
|
3.69%
|
-63.3%
|
42%
|
48.5%
|
48.2%
|
-34.9%
|
ROA (Net income/ Total Assets)
|
3.56%
|
1.51%
|
11.4%
|
22.9%
|
20.8%
|
-11.7%
|
Assets
1 |
619.3
|
-16,421
|
1,527
|
1,416
|
2,357
|
2,954
|
Book Value Per Share
2 |
0.3000
|
0.1700
|
0.2600
|
0.4100
|
0.6100
|
0.3900
|
Cash Flow per Share
2 |
0.1300
|
0.2200
|
0.2300
|
0.4600
|
0.5900
|
0.3400
|
Capex
1 |
17.7
|
3.33
|
6.33
|
22.3
|
9.96
|
126
|
Capex / Sales
|
1.35%
|
0.32%
|
0.55%
|
1.02%
|
0.41%
|
20.98%
|
Announcement Date
|
4/9/19
|
4/15/20
|
4/12/21
|
4/6/22
|
4/11/23
|
4/8/24
|
|
1st Jan change
|
Capi.
|
---|
| -19.23% | 30.64M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|